UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011593 |
|---|---|
| Receipt number | R000013556 |
| Scientific Title | Phase II clinical trial of combination of personalized peptide vaccination, Cyclophosphamide and Imiquimod for advanced Pancreatic cancer patients who failed standard therapy. |
| Date of disclosure of the study information | 2013/08/28 |
| Last modified on | 2017/11/10 15:42:54 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/08/27 22:44:19 | ||
| 2 | Update | 2014/01/15 09:26:30 | Recruitment status |
|
| 3 | Update | 2014/12/12 17:23:32 | Key inclusion criteria Key inclusion criteria |
|
| 4 | Update | 2017/11/10 15:42:54 | Recruitment status |
